Coherus Oncology, Inc.
USD1.45
-0.05 (-3.33%)
CEO
Dennis Lanfear
IPO Date
2014-11-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.52
Prev. Close
$1.50
Day Low
$1.44
Day High
$1.52
52W Low
$0.72
52W High
$2.62
Market Cap
$0.18B
Volume
1.03M
| 5.5 |
| 31 Dec 2023 | FY | 38.2% | -92.5% | 123.0% | -37.8% | -2.49 | 1.43 | -1.3 |
| 31 Dec 2022 | FY | 66.8% | -138.2% | 212.3% | -60.7% | -3.50 | 2.75 | -2.1 |
| 31 Dec 2021 | FY | 82.4% | -87.9% | -293.8% | -42.3% | 4.29 | 3.64 | -4.2 |
| 31 Dec 2020 | FY | 92.1% | 27.8% | 47.1% | 15.7% | 1.48 | 5.27 | 9.4 |
| 31 Dec 2019 | FY | 95.2% | 25.2% | 85.4% | 22.0% | 1.79 | 2.98 | 14.0 |
| 31 Dec 2018 | FY | -107.9% | -13453.7% | 542.5% | -210.5% | -2.67 | 2.18 | -2.8 |
| 31 Dec 2017 | FY | -10216.9% | -15306.6% | -780.0% | -146.5% | 3.32 | 4.47 | -2.0 |
| 31 Dec 2016 | FY | -33.8% | -67.0% | -657.9% | -71.3% | 5.18 | 2.22 | -9.3 |
| -1.1 |
| 30 Sept 2025 | Q3 | 59.5% | -303.4% | -40.0% | -6.8% | 0.46 | 1.23 | -1.4 |
| 30 Jun 2025 | Q2 | 57.0% | -403.1% | -34.5% | -9.4% | 0.34 | 1.43 | -0.5 |
| 31 Mar 2025 | Q1 | 51.3% | -744.4% | 30.8% | -15.2% | -1.47 | 1.22 | -0.4 |
| 31 Dec 2024 | Q4 | 37.5% | -93.6% | 38.4% | -11.3% | -2.04 | 1.21 | -0.8 |
| 30 Sept 2024 | Q3 | 70.7% | -15.2% | 12.2% | -2.1% | -3.07 | 1.25 | -2.8 |
| 30 Jun 2024 | Q2 | 54.5% | -19.9% | 15.4% | -1.9% | -3.55 | 1.21 | -3.6 |
| 31 Mar 2024 | Q1 | 37.7% | 4457.3% | -125.7% | 13.5% | -5.88 | 1.17 | 0.7 |
| 31 Dec 2023 | Q4 | 7.6% | -87.0% | 41.2% | -12.7% | -2.49 | 1.43 | -1.2 |